6-Bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine

Catalog No. :
ACFKQU319
CAS No. :
1823884-05-4
Molecular Formula :
C9H8BrClN2
Molecular Weight :
259.53

IUPAC Name:6-bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine

6-Bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$379.00Login to see priceInquiryInquiry
1g95%$950.00Login to see priceInquiryInquiry
5g95%$2852.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine
IUPAC Name6-bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine
MDL No.MFCD26383881
Molecular FormulaC9H8BrClN2
Molecular Weight259.53
SMILESCC1=C(C=CC2=NC(CCl)=CN12)Br
InChI KeyCCQVXCCCHGGRTG-UHFFFAOYSA-N
Synonym6-bromo-2-(chloromethyl)-5-methylimidazo[1,2-a]pyridine(WXC04556);6-BROMO-2-(CHLOROMETHYL)-5-METHYLIMIDAZO[1,2-A]PYRIDINE;Imidazo[1,2-a]pyridine, 6-bromo-2-(chloromethyl)-5-methyl-
CAS No.1823884-05-4

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACFKQU319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFKQU319 route product structure diagram
    ACFKQU3191823884-05-4
Inquiry

2. ACFKQU319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Then
  5. ACFKQU319 route product structure diagram
    ACFKQU3191823884-05-4
Inquiry

Comments (0)